Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Opgen Inc
(NQ:
OPGN
)
2.680
USD
+0.720 (+36.73%)
Official Closing Price
Updated: 7:59 PM EST, Mar 8, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Opgen Inc
< Previous
1
2
3
4
Next >
OpGen Provides Update on Curetis Group Company Ares Genetics’ Collaboration with BGI Group to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe
January 30, 2020
From
GlobeNewswire News Releases
OpGen Achieves Key Milestone in Planned Business Combination with Curetis
January 28, 2020
From
GlobeNewswire News Releases
OpGen Provides Update on Curetis Group Business Receiving U.S. FDA 510(k) Clearance of its Unyvero LRT for BAL Specimens
December 23, 2019
From
GlobeNewswire News Releases
OpGen Provides Curetis Group Business Update and Announces Completion of Key Milestones in Planned Business Combination
December 02, 2019
From
GlobeNewswire News Releases
Curetis Publishes Third Quarter and 9-Month Business and Financial Update
November 25, 2019
From
GlobeNewswire News Releases
OpGen Products in Development to Address “Urgent Threat” Pathogens Highlighted in New CDC Report on Antibiotic Resistance Threats
November 19, 2019
From
GlobeNewswire News Releases
Curetis Provides Business Update for the First Nine Months of 2019
November 14, 2019
From
GlobeNewswire News Releases
OpGen Reports Third Quarter 2019 Financial Results and Provides Business Update
November 06, 2019
From
GlobeNewswire News Releases
OpGen Provides Update on Curetis Group Company Ares Genetics Business
November 04, 2019
From
GlobeNewswire News Releases
OpGen Announces Date of Third Quarter 2019 Financial Results Conference Call
October 29, 2019
From
GlobeNewswire News Releases
OpGen Announces Closing of $9.4 Million Underwritten Public Offering
October 28, 2019
From
GlobeNewswire News Releases
OpGen Announces Pricing of $9.4 Million Underwritten Offering
October 23, 2019
From
GlobeNewswire News Releases
U.S. Patent Allowed Covering Acuitas Lighthouse® Software
October 23, 2019
From
GlobeNewswire News Releases
OpGen Presents Preliminary Acuitas® AMR Gene Panel Data for Detecting Urinary Tract Infections
October 07, 2019
As showcased at IDWeek 2019 - Test results show parity with urine culture and whole genome sequencing results
From
GlobeNewswire News Releases
OpGen to Present on Guiding Precision Antibiotic Therapy with Rapid Genomics and Informatics at IDWeek 2019
September 26, 2019
Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software to be highlighted in a conference speaker session
From
GlobeNewswire News Releases
OpGen Provides update on Curetis Group’s R&D Collaboration
September 18, 2019
From
GlobeNewswire News Releases
Curetis Reports Financial Results for the First Six Months of 2019
September 18, 2019
From
GlobeNewswire News Releases
Thinking about buying stock in Aurora Cannabis, Box, OpGen, Tilray, or Top Ships?
September 04, 2019
InvestorsObserver issues critical PriceWatch Alerts for ACB, BOX, OPGN, TLRY, and TOPS.
From
PR Newswire
Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses
September 04, 2019
From
GlobeNewswire News Releases
Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses
September 04, 2019
From
GlobeNewswire News Releases
OpGen Reports Second Quarter 2019 Financial Results and Provides Business Update
August 07, 2019
From
GlobeNewswire News Releases
OpGen Announces Date of Second Quarter 2019 Financial Results Conference Call
July 30, 2019
OpGen, Inc. (NASDAQ: OPGN) announced today that the Company will report its second quarter 2019 financial results after the close of the U.S. financial markets on Wednesday, August 7, 2019. OpGen’s...
From
GlobeNewswire News Releases
OpGen’s Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy
June 27, 2019
OpGen, Inc. (Nasdaq: OPGN) today announced the presentation of data obtained from the first multisite assessment evaluating the potential clinical utility of its Acuitas® AMR Gene Panel using clinical...
From
GlobeNewswire News Releases
OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection
June 13, 2019
Findings from major health centers to be presented at ASM Microbe 2019
From
GlobeNewswire News Releases
OpGen Reports First Quarter 2019 Financial Results and Provides Business Update
May 14, 2019
OpGen, Inc. (NASDAQ: OPGN) today reported financial and operating results for the three months ended March 31, 2019 and provided a business update. Total revenue for the first quarter of 2019 was $1.0...
From
GlobeNewswire News Releases
OpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify Presence of Antibiotic Resistance
May 14, 2019
New molecular test designed to detect 47 antibiotic-resistance genes with high sensitivity and specificity in less than three hours, empowering healthcare facilities to make more informed infection...
From
GlobeNewswire News Releases
OpGen Announces Date of First Quarter 2019 Financial Results Conference Call
May 07, 2019
OpGen, Inc. (NASDAQ: OPGN) announced today that the Company will report its first quarter 2019 financial results after the close of the U.S. financial markets on Tuesday, May 14, 2019. OpGen’s...
From
GlobeNewswire News Releases
Investor Expectations to Drive Momentum within Salem Media Group, OpGen, Fibrocell Science, and Ur Energy — Discovering Underlying Factors of Influence
April 30, 2019
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Salem Media Group, Inc....
From
GlobeNewswire News Releases
OpGen Announces Closing of Public Offering of Common Stock
March 29, 2019
OpGen, Inc. (Nasdaq: OPGN) announced today the closing of its previously announced underwritten public offering of 9 million shares of its common stock at a public offering price of $0.60 per share....
From
GlobeNewswire News Releases
OpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy Journal
March 28, 2019
Pivotal data supports use of Acuitas Lighthouse® Software for prediction of antibiotic resistance
From
GlobeNewswire News Releases
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.